Zydus Lifesciences has announced that Ampliman 2, France, a wholly-owned subsidiary of Zydus MedTech (France) S.A.S., has been dissolved without liquidation, effective January 9, 2026. The assets and liabilities of Ampliman 2 have been transferred to Zydus MedTech (France) S.A.S. The dissolution is not expected to impact the company’s business operations.
Subsidiary Dissolution
Zydus Lifesciences has announced the dissolution of its subsidiary, Ampliman 2, France. The dissolution was effective as of January 9, 2026.
Details of the Dissolution
Ampliman 2 was a wholly-owned subsidiary of Zydus MedTech (France) S.A.S. As a result of the dissolution, all assets and liabilities have been transferred to Zydus MedTech (France) S.A.S.
Impact on Operations
The company has stated that the dissolution of Ampliman 2 will not have any impact on its overall business operations.
Source: BSE
